Design, synthesis and metabolic regulation effect of farnesoid X receptor (FXR) antagonistic benzoxepin-5-ones

被引：1
|
作者：
Guo-Ning Zhang [1 ,2 ]
Yi Huan [1 ]
Xing Wang [1 ]
Su-Juan Sun [1 ]
Zhu-Fang Shen [1 ]
Wei-Shuo Fang [1 ]
机构：
[1] State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College
[2] Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Peking Union Medical College
来源：
ChineseChemicalLetters | 2017年 / 28卷 / 07期
关键词：
Farnesoid X receptor; Antagonist; Benzoxepin-5-one; Triglyceride; Plasma ALT;
D O I：
暂无
中图分类号：
TQ460.1 [基础理论];
学科分类号：
1007 ;
摘要：
A series of benzoxepin-5-ones were designed and synthesized by the cyclization of chalcones which were previously found as FXR antagonists. The cellular FXR antagonism of benzoxepines was investigated,among which the most potent compound 10 l was able to reduce the plasma and hepatic triglyceride and plasma ALT levels in mice.
引用
收藏
页码：1519 / 1522
页数：4
相关论文
共 50 条
  • [31] Design, synthesis, and biological studies of novel 3-benzamidobenzoic acid derivatives as farnesoid X receptor partial agonist
    Hu, Lijun
    Ren, Qiang
    Deng, Liming
    Zhou, Zongtao
    Cai, Zongyu
    Wang, Bin
    Li, Zheng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 211
  • [32] A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice
    Wang, Xiaoxin X.
    Luo, Yuhuan
    Wang, Dong
    Adorini, Luciano
    Pruzanski, Mark
    Dobrinskikh, Evgenia
    Levi, Moshe
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (29) : 12018 - 12024
  • [33] INT 767-A NOVEL DUAL FARNESOID-X RECEPTOR (FXR) AND TAKEDA G-PROTEIN-COUPLED RECEPTOR-5 (TGR5) AGONIST ATTENUATES INTESTINAL ISCHEMIA REPERFUSION INJURY
    Canovai, Emilio
    Farre, Ricard
    Accarie, Alison
    De Hertogh, Gert
    Vanuytsel, Tim
    Pirenne, Jacques
    Ceulemans, Laurens J.
    TRANSPLANTATION, 2020, 104 (09) : S167 - S168
  • [34] THE FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (OCA) INCREASES PLASMA FGF-19 CONCENTRATIONS AND DECREASES BILE ACID SYNTHESIS IN PRIMARY BILIARY CIRRHOSIS (PBC)
    Marschall, H. -U.
    Luketic, V.
    Lovgren-Sandblom, A.
    Benthin, L.
    Kowdley, K.
    Hirschfield, G.
    Mason, A.
    Lindor, K.
    Gordon, S.
    Vincent, C.
    Chapman, R.
    Mayo, M.
    Burroughs, A.
    Pares, A.
    Jones, D.
    Schramm, C.
    Eliot, L.
    Hofmann, A. F.
    Shapiro, D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S377 - S377
  • [35] Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism
    Pathak, Preeti
    Liu, Hailiang
    Boehme, Shannon
    Xie, Cen
    Krausz, Kristopher W.
    Gonzalez, Frank
    Chiang, John Y. L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (26) : 11055 - 11069
  • [36] INT-767-A Dual Farnesoid-X Receptor (FXR) and Takeda G Protein-Coupled Receptor-5 (TGR5) Agonist Improves Survival in Rats and Attenuates Intestinal Ischemia Reperfusion Injury
    Canovai, Emilio
    Farre, Ricard
    Accarie, Alison
    Lauriola, Mara
    De Hertogh, Gert
    Vanuytsel, Tim
    Pirenne, Jacques
    Ceulemans, Laurens J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [37] Back door modulation of the farnesoid X receptor: Design, synthesis, and biological evaluation of a series of side chain modified chenodeoxycholic acid derivatives
    Pellicciari, Roberto
    Gioiello, Antimo
    Costantino, Gabriele
    Sadeghpour, Bahman M.
    Rizzo, Giovanni
    Meyer, Udo
    Parks, Derek J.
    Entrena-Guadix, Antonio
    Fiorucci, Stefano
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) : 4208 - 4215
  • [38] Farnesoid X receptor induces cell death and sensitizes to TRAIL-induced inhibition of growth in colorectal cancer cells through the up-regulation of death receptor 5
    Hotta, Masahiro
    Sakatani, Takashi
    Ishino, Kousuke
    Wada, Ryuichi
    Kudo, Mitsuhiro
    Yokoyama, Yasuyuki
    Yamada, Takeshi
    Yoshida, Hiroshi
    Naito, Zenya
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 519 (04) : 824 - 831
  • [39] Design and identification of a new farnesoid X receptor (FXR) partial agonist by computational structure-activity relationship analysis: Ligand-induced H8 helix fluctuation in the ligand-binding domain of FXR may lead to partial agonism
    Gohda, Keigo
    Iguchi, Yusuke
    Masuda, Arisa
    Fujimori, Ko
    Yamashita, Yukiko
    Teno, Naoki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 41
  • [40] TRIMETHYLAMINE N-OXIDE AGGRAVATES HEPATIC STEATOSIS THROUGH UP-REGULATION OF BILE ACIDS SYNTHESIS AND ACTIVATION OF ENDOGENOUS HEPATIC FARNESOID-X-RECEPTOR
    Zhu, Hui-lian Zhu
    Zhu, Hui-lian Zhu
    ANNALS OF NUTRITION AND METABOLISM, 2017, 71 : 961 - 962
12345